Hui-kuo G. Shu
Distinguished in Ependymoma

Dr. Hui-kuo G. Shu

Radiation Oncology
Emory health
Emory Winship Cancer Institute
1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
33 Years of Experience

Distinguished in Ependymoma
Emory health
Emory Winship Cancer Institute
1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hui-kuo Shu is a Radiation Oncologist in Atlanta, Georgia. Dr. Shu has been practicing medicine for over 33 years and is rated as a Distinguished provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, and Glioma.

His clinical research consists of co-authoring 110 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Case Western Reserve University, 1993.0
Residency
UCSF Medical Center
Specialties
Radiation Oncology
Licenses
Radiology in GA
Board Certifications
American Board Of Radiology, 1999
Hospital Affiliations
Emory University Hospital Midtown
Emory University Hospital
Saint Joseph's Hospital Of Atlanta, Inc
Languages Spoken
English
Mandarin
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Emory Winship Cancer Institute
1365 Clifton Road Northeast, BldgC, Atlanta, GA 30322
Call: 404-778-3473

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Phase III Trial of Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
A Phase III Trial of Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Enrollment Status: Recruiting
Publish Date: January 13, 2026
Intervention Type: Radiation, Procedure, Drug
Study Drug: Memantine
Study Phase: Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Pilot Study of Subcutaneously Administered Natural Progesterone for the Treatment of Recurrent GBM
Pilot Study of Subcutaneously Administered Natural Progesterone for the Treatment of Recurrent GBM
Enrollment Status: Active_not_recruiting
Publish Date: January 07, 2026
Intervention Type: Other, Biological
Study Drug: Therapeutic Progesterone
Study Phase: Early Phase 1
Pilot Study of Spectroscopic MRI-Guided, Dose-Escalated Radiation Therapy for Newly-Diagnosed Glioblastoma
Pilot Study of Spectroscopic MRI-Guided, Dose-Escalated Radiation Therapy for Newly-Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Drug, Procedure, Radiation
Study Drug: Temozolomide
Study Phase: Phase 2
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
Whole Brain Radiation Therapy With Simultaneous Boost to Gross Metastatic Tumor Volume Using Volumetric Modulated Arc Therapy (RapidArc)
Whole Brain Radiation Therapy With Simultaneous Boost to Gross Metastatic Tumor Volume Using Volumetric Modulated Arc Therapy (RapidArc)
Enrollment Status: Completed
Publish Date: June 29, 2021
Intervention Type: Radiation
Study Phase: Not Applicable
View 5 Less Clinical Trials

112 Total Publications

Incidental High-Grade Sellar Solitary Fibrous Tumor Mimicking Non-Functioning Pituitary Adenoma: A Case Report and Literature Review.
Incidental High-Grade Sellar Solitary Fibrous Tumor Mimicking Non-Functioning Pituitary Adenoma: A Case Report and Literature Review.
Journal: The American journal of case reports
Published: March 15, 2025
View All 112 Publications
Similar Doctors
Bree Eaton
Advanced in Ependymoma
Dr. Bree Eaton
Radiation Oncology
Advanced in Ependymoma
Dr. Bree Eaton
Radiation Oncology

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
 (0.1 miles away)
404-778-3473
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bree Eaton is a Radiation Oncologist in Atlanta, Georgia. Dr. Eaton has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Ependymoma. Her top areas of expertise are Posterior Fossa Tumor, Brain Tumor, Glioma, Embryonal Tumor with Multilayered Rosettes, and Glossectomy.

Leonel Kahn
Advanced in Ependymoma
Dr. Leonel Kahn
Radiation Oncology
Advanced in Ependymoma
Dr. Leonel Kahn
Radiation Oncology

Piedmont Physicians Radiation Oncology Kennesaw

187 Chastain Rd Nw, Ste 120, 
Kennesaw, GA 
 (22.7 miles away)
770-218-6480
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leonel Kahn, MD is a board-certified radiation oncologist with Peachtree Radiation Oncology Services. He joined the group in 2018 and practices at Piedmont Kennesaw, Piedmont Atlanta Hospital, and Piedmont West. He practices general radiation oncology and has extensive experience with modern radiation oncology techniques (intensity modulated radiation therapy, image guided radiation therapy, and stereotactic body radiotherapy). He has a special interest in gastrointestinal, breast, and central nervous system malignancies. He has additional training in stereotactic radiosurgery (Gamma Knife and linear accelerator-based radiosurgery) for malignant and benign conditions.Dr. Kahn is an enthusiastic and committed physician. His skill sets are particularly suited to bridge the gap between the systematic processes of treatment planning and delivery versus the warmhearted nature of caring for cancer patients. He is a critical thinker and enjoys the process of assimilating scientific evidence with patient-specific factors to determine the best treatment decision. His experience has refined his ability to make decisive choices in the face of complex cancer care. He also establishes deep bonds with his patients, grounded in compassion and empathy. He thrives on the demanding nature of the profession in terms of learning and updating his knowledge base as the field constantly evolves. Importantly, radiation oncology is a field in which he feels endlessly honored and humbled to work.In addition to his clinical responsibilities, he is a voting member of the Piedmont Healthcare Institutional Review Board. He also has comprehensive training in clinical trial enrollment to national cooperative group protocols. He enjoys discussing potential clinical trials with patients, if it is in line with their wishes.He attended Tulane University in New Orleans, Louisiana, where he received a Bachelor of Science in Neuroscience (Summa Cum Laude). He then earned his medical degree from Oregon Health and Science University in Portland, Oregon. For his graduate medical education, he performed an internship at Legacy Health System in Portland, Oregon and completed a radiation oncology residency at the University of California, Davis Comprehensive Cancer Center in Sacramento, California. He served as chief radiation oncology resident during his final year. Dr. Kahn was born in Louisiana, but raised in Eugene, Oregon. Walking his corgi dog and cooking are the two ways he spends most of his weekends. He is also very happily married. Dr. Kahn is rated as a Distinguished provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Anal Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Pleuropulmonary Blastoma.

Chad A. Levitt
Advanced in Ependymoma
Dr. Chad A. Levitt
Radiation Oncology
Advanced in Ependymoma
Dr. Chad A. Levitt
Radiation Oncology
1968 Peachtree Rd Nw, Radiation Oncology Dept, 
Atlanta, GA 
 (4.1 miles away)
404-605-3319
Languages Spoken:
English
See accepted insurances
Accepting New Patients

A board-certified radiation oncologist and Atlanta-native, Dr. Chad Levitt completed his doctorate and residency at Emory University's School of Medicine in Atlanta. Dr. Levitt has served as clinical director of oncology practices previously in both Denver, Colorado as well as in Florida. Most recently he founded his private practice in Cummings, GA, where he served the North Atlanta community since 2008 until joining Peachtree Radiation Oncology in 2016. Dr. Levitt has been nominated by his peers and colleagues as a Castle Connolly Top Doctor in Atlanta since 2014. With over 15 years of experience in the treatment of cancer, Dr. Levitt has, over the years, been at the forefront of radiation treatment techniques, innovations and practices. He is a national speaker and has published clinical studies in multiple peer reviewed oncology journals. He has served on national advisory boards and working groups throughout his career as well as having been the practice liaison and Principal Investigator for RTOG and US Oncology research protocols. Dr. Levitt strives to put himself in his patients' shoes as he considers all aspects of their care plan. Central to his philosophy is the interest in providing care beyond mere treatment, and this passion complements his role within each of his patients' treatment teams. He and his wife, Alisha, are fortunate to be able to raise their three children in their native city close to their extended family. In his spare time Dr. Levitt enjoys rock climbing, playing guitar, coaching soccer, camping with his family and woodworking. Dr. Levitt is rated as an Advanced provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

VIEW MORE EPENDYMOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shu's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Shu is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Glioblastoma
    Dr. Shu is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Distinguished
  • Acoustic Neuroma
    Dr. Shu is
    Distinguished
    . Learn about Acoustic Neuroma.
    See more Acoustic Neuroma experts
  • Arteriovenous Malformation
    Dr. Shu is
    Distinguished
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Shu is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Brain Tumor
    Dr. Shu is
    Distinguished
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Craniopharyngioma
    Dr. Shu is
    Distinguished
    . Learn about Craniopharyngioma.
    See more Craniopharyngioma experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Shu is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
View All 19 Distinguished Conditions
  • Advanced
  • Cerebral Ventricle Cancer
    Dr. Shu is
    Advanced
    . Learn about Cerebral Ventricle Cancer.
    See more Cerebral Ventricle Cancer experts
  • Glomus Jugulare Tumor
    Dr. Shu is
    Advanced
    . Learn about Glomus Jugulare Tumor.
    See more Glomus Jugulare Tumor experts
  • Glomus Tympanum Tumor
    Dr. Shu is
    Advanced
    . Learn about Glomus Tympanum Tumor.
    See more Glomus Tympanum Tumor experts
  • Melanoma of the Eye
    Dr. Shu is
    Advanced
    . Learn about Melanoma of the Eye.
    See more Melanoma of the Eye experts
  • Neuroepithelioma
    Dr. Shu is
    Advanced
    . Learn about Neuroepithelioma.
    See more Neuroepithelioma experts
  • Orbital Pseudotumor
    Dr. Shu is
    Advanced
    . Learn about Orbital Pseudotumor.
    See more Orbital Pseudotumor experts
View All 9 Advanced Conditions
  • Experienced
  • Acinic Cell Carcinoma of Salivary Glands
    Dr. Shu is
    Experienced
    . Learn about Acinic Cell Carcinoma of Salivary Glands.
    See more Acinic Cell Carcinoma of Salivary Glands experts
  • Adenoid Cystic Carcinoma
    Dr. Shu is
    Experienced
    . Learn about Adenoid Cystic Carcinoma.
    See more Adenoid Cystic Carcinoma experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Shu is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Anal Cancer
    Dr. Shu is
    Experienced
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Bone Tumor
    Dr. Shu is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Brain Stem Cancer
    Dr. Shu is
    Experienced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.